ADIL

Adial Pharmaceuticals, Inc - Common Stock (ADIL)

About Adial Pharmaceuticals, Inc - Common Stock (ADIL)

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Details

Daily high

$0.27

Daily low

$0.24

Price at open

$0.26

52 Week High

$1.30

52 Week Low

$0.22

Market cap

6.4M

Dividend yield

0.00%

Volume

13,467

Avg. volume

318,670

P/E ratio

-.26

Adial Pharmaceuticals, Inc - Common Stock News